Veterinary pharmaceutical company Dechra announced Thursday the appointment of Anne-Francoise Nesmes as Chief Financial Officer.
Nesmes joins the company on April 22nd from GlaxoSmithKline where she has worked since 1997 in a number of finance roles including Senior Vice-President, Finance of Vaccines in Belgium.
She has also held finance positions with John Crane, Tetra Pak, ADP and Caterpillar UK.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
The French national, who holds an MBA from Henley Management College and a Master in Management Sciences from Grenoble Business School, started her career in the UK before moving to Belgium, Sweden, and the US.
She will relocate to the UK on taking up her position with the group.
Mike Redmond, Chairman of Dechra, said: "We are delighted that Anne-Francoise is joining Dechra. She is a high calibre finance professional who also has valuable international, pharmaceutical, manufacturing and commercial experience. She will be a welcome addition to the executive team.
"I, and the rest of the board, look forward to working with Anne-Francoise to continue to progress our strategy of delivering a high growth, cash generative, specialist veterinary products business."
RD
-
UK-US trade deal announced: US cuts tariffs on UK car imports to 10%Keir Starmer and Donald Trump have announced a UK-US trade deal, but the US president has refused to lift baseline tariffs on most UK goods. What does it mean for the UK?
-
How to use mid-caps to diversify from the USMedium sized companies are overlooked by investors but could offer an attractive ‘sweet spot’. We consider the case for mid-caps amid market volatility.
